No abstract available
Keywords:
Activated partial thromboplastin time (aPTT); Acute respiratory distress syndrome (ARDS); Anti-Xa; COVID-19; Coagulopathy; Extracorporeal membrane oxygenation (ECMO); Heparin.
MeSH terms
-
Anticoagulants / adverse effects
-
COVID-19*
-
Extracorporeal Membrane Oxygenation*
-
Heparin / adverse effects
-
Humans
-
Partial Thromboplastin Time
-
Retrospective Studies
-
SARS-CoV-2